ALPHA CAPITAL AKTIENGESELLSCHAFT 13D/13G Filings for Artelo Biosciences, Inc. (ARTL)

ALPHA CAPITAL AKTIENGESELLSCHAFT 13D and 13G filings for Artelo Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-15
11:30 am
Sale
2020-12-31 13G Artelo Biosciences, Inc.
ARTL
ALPHA CAPITAL AKTIENGESELLSCHAFT 52,267
4.990%
-1,066decrease
(-2.00%)
Filing
2020-10-22
1:18 pm
Purchase
2020-10-14 13G Artelo Biosciences, Inc.
ARTL
ALPHA CAPITAL AKTIENGESELLSCHAFT 53,333
5.290%
53,333increase
(New Position)
Filing